|国家预印本平台
首页|Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

来源:bioRxiv_logobioRxiv
英文摘要

Abstract Patient-derived models are transforming translational cancer research. It is not clear if the emergence of patient-derived organoid (PDO) models can extend the utility of the widely used patient-derived xenograft (PDX). In addition, the utility of PDO models for serum biomarker discovery is not known. Here, we demonstrate that PDO models recapitulate the genomics, cell biology, glycomics and drug responses observed in PDX models. Furthermore, we demonstrate the applicability of PDO models for identification of N-glycans that are enriched in the glycome of pancreatic ductal adenocarcinoma (PDAC). Surprisingly, among all the glycans observed in PDX and PDOs, a core set of 57 N-glycans represent 50-94% of the relative abundance of all N-glycans detected, suggesting that only a subset of glycans dominate the cell surface landscape in PDAC. In addition, we outline a tumor organoid-based pipeline to identify surface proteins in extracellular vesicles (EV) from media supernatant of PDO cultures. When combined with the affinity-based validation platform, the EV surface proteins discovered in PDOs are effective in differentiating patients with PDAC from those with benign pancreatitis in the clinic, identifying PDO as powerful discovery platform for serum biomarkers. Thus, PDOs extend the utility of the archival collections of PDX models for translational research and function as a powerful platform for identification of clinically-actionable biomarkers in patients blood. Significance statementTumor organoids extend the utility of PDX models as platforms for investigating drug response, glycosylation changes and function as new platforms for discovering blood-based biomarkers

Bose Arindam、Bockorny Bruno、Akshinthala Dipikaa、Sanchez-Gonzalez Veronica、Rouse Emily E、Lehoux Sylvain D.、Pandell Nicole、Cummings Richard D、Muthuswamy Lakshmi B、Gonzalez Raul、Daaboul George、Clohessy John G.、Freedman Steven D.、Gandarilla Omar、Grossman Joseph、Paul Indranil、Sawhney Mandeep S.、Hidalgo Manuel、Emili Andrew、Pino Sofia Perea Del、Muthuswamy Senthil K、Huang Ling

Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolNanoView BiosciencesDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolNanoView BiosciencesCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Translational Research and Technology Innovation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartments of Biology and Biochemistry, Boston UniversityDivision of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartments of Biology and Biochemistry, Boston UniversityCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School||Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Translational Research and Technology Innovation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolCancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School||Division of Genetics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

10.1101/513267

医学研究方法肿瘤学生物科学研究方法、生物科学研究技术

Bose Arindam,Bockorny Bruno,Akshinthala Dipikaa,Sanchez-Gonzalez Veronica,Rouse Emily E,Lehoux Sylvain D.,Pandell Nicole,Cummings Richard D,Muthuswamy Lakshmi B,Gonzalez Raul,Daaboul George,Clohessy John G.,Freedman Steven D.,Gandarilla Omar,Grossman Joseph,Paul Indranil,Sawhney Mandeep S.,Hidalgo Manuel,Emili Andrew,Pino Sofia Perea Del,Muthuswamy Senthil K,Huang Ling.Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers[EB/OL].(2025-03-28)[2025-06-28].https://www.biorxiv.org/content/10.1101/513267.点此复制

评论